Sugammadex Disease Interactions
There are 3 disease interactions with sugammadex.
Sugammadex (applies to sugammadex) bleeding
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Coagulation Defect
Sugammadex increases the risk of coagulopathies and bleeding. It is recommended to carefully monitor coagulation parameters in patients with known coagulopathies being treated with therapeutic anticoagulation, receiving thromboprophylaxis drugs, other than heparin and low molecular weight heparin.
Sugammadex (applies to sugammadex) liver dysfunction
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Liver Disease
Sugammadex is not metabolized nor excreted by the liver. It is recommended to use caution when administering sugammadex to patients with hepatic impairment as no dedicated trials have been conducted in these patients.
Sugammadex (applies to sugammadex) renal impairment
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Renal Dysfunction
Sugammadex is substantially excreted by the kidney, and the risk of toxic reactions to this drug may be higher in patients with impaired renal function. Dosage adjustment is not required in patients with mild to moderate renal impairment. Sugammadex is not recommended for use in patients with severe renal impairment, including those requiring dialysis, due to insufficient safety information combined with the prolonged and increased overall exposure in these patients.
Switch to professional interaction data
Sugammadex drug interactions
There are 28 drug interactions with sugammadex.
Report options
More about sugammadex
- sugammadex consumer information
- Check interactions
- Compare alternatives
- Reviews (2)
- Side effects
- Dosage information
- During pregnancy
- Drug class: miscellaneous central nervous system agents
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Mestinon
Mestinon (pyridostigmine) is used to increase muscle strength in conditions such as myasthenia ...
Bridion
Bridion is used for reversal of neuromuscular blockade, reversal of nondepolarizing muscle relaxants
Tavneos
Tavneos (avacopan) is a C5a receptor antagonist used for severe active ANCA-associated vasculitis ...
Regonol
Regonol is used for dysautonomia, myasthenia gravis, nerve agent pretreatment, reversal of ...
Prostigmin Bromide
Prostigmin Bromide is used for myasthenia gravis, urinary retention
Glycopyrrolate/neostigmine
Glycopyrrolate/neostigmine systemic is used for reversal of neuromuscular blockade
Edrophonium
Edrophonium systemic is used for reversal of nondepolarizing muscle relaxants
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.